
QHP Capital Names Owen Murray as CEO of Bend, CoreRx, and Societal
QHP Capital has announced the appointment of Owen Murray as the new Chief Executive Officer for the recently combined entities of Bend Bioscience, CoreRx, and Societal. Murray, who most recently served as CEO of Aprecia Pharmaceutical, brings over 25 years